DART and Laboratory Monitoring of HIV Treatment. The Lancet, 375 (9719): 979.

In by AHF

Efficacy, Safety, and Tolerability of Etravirine With and Without Darunavir/Ritonavir or Raltegravir in Treatment-Experienced Patients: Analysis of the Etravirine Early Access Program in the United States. Journal of Acquired Immune Deficiency Syndrome, 53(5): 614-618.
Stop the Sores: The Making and Evaluation of a Successful Social Marketing Campaign. Health Promotion Practice, 11(1): 23-33.
Download
File Type: pdf
Categories: 2010
Tags: 2010-2014
Author: Khanlou H, Manchanda R, Reis P, Saavedra J, Sayana S, Weinstein M